Chronic Lymphocytic Leukemia Clinical Trial

Transplantation for Patients With Chronic Lymphocytic Leukemia

Summary

To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of leukemia-cll/" >chronic lymphocytic leukemia.

View Full Description

Full Description

To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:- adequate organ function

normal bone marrow cytogenetics Exclusion Criteria:- active CNS disease
For autologous patients more than 30% bone marrow involvement

Study is for people with:

Chronic Lymphocytic Leukemia

Estimated Enrollment:

28

Study ID:

NCT00186303

Recruitment Status:

Completed

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford University School of Medicine
Stanford California, 94305, United States

How clear is this clinincal trial information?

Study is for people with:

Chronic Lymphocytic Leukemia

Estimated Enrollment:

28

Study ID:

NCT00186303

Recruitment Status:

Completed

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider